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Previewsneurons thought to underlie the plasticity
necessary for certain types of learning
and memory, was enhanced in these
animals. These results provide compelling
evidence that the greater cognitive
sophistication of humans compared to
mice is at least in part due to differences
in their glia.
By beginning to explore a role for glia
in higher cognitive function, this study
raises intriguing questions about exactly
what, and how extensive, these roles
might be; for example, are other domains
of cognition affected? Furthermore, it
would be of interest to examine the
effects of engrafting human glia on other
important forms of plasticity, such as
long-term depression (LTD). Further
exploration of exactly what role glia play
in these and in other processes would
ultimately be fascinating.
This paper, which promises to be a
landmark for glial cell biology, provides
a wonderful example of how stem cell
biology can be used to address funda-
mental questions of physiology. In a266 Cell Stem Cell 12, March 7, 2013 ª2013sense, this study harks back to the
early days of glial cell transplantation,
where this procedure represented a
powerful experimental tool to study how
glia interacted with each other and with
neurons (Blakemore and Franklin, 1991).
The finding that transplanted glial
progenitors were able to remyelinate
demyelinated axons meant that the
technique quickly became diverted
toward possible therapeutic objectives,
a route which has now crossed the
translational chasm, with the publication
of the outcome of initial cell therapies
for inherited disorders of myelination
(Gupta et al., 2012). While these develop-
ments are immensely encouraging, it is
nevertheless important that the research
community fully harness the power of
stem cells to explore physiology: this
paper provides just such an example,
elegantly revealing the functional inter-
play between neurons and glia. Perhaps,
after all, it is neither your neurons nor
your glia that make you clever, but both,
working in tandem.Elsevier Inc.REFERENCES
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Although SOX2 has been identified as a squamous cell carcinoma oncogene, mechanisms of SOX2-induce
oncogenesis have remained elusive. In this issue of Cell Stem Cell, Li et al. (2013) show that SOX2 synergizes
with inflammation-induced STAT3 activation to transform basal progenitors and initiate squamous cell
carcinoma.The genes and pathways that are essen-
tial for the maintenance of stem and
progenitor cell populations seem ideally
suited to being hijacked by developing
cancers. Indeed, cancer genomes
commonly contain alterations leading toaberrant activation or inactivation of
members of key developmental transcrip-
tion factors and key developmental
signaling pathways, such as WNT, notch,
and hedgehog. An important but little
understood example of this phenomenonis that of SOX2, which is a transcription
factor recently recognized to be essential
for development and maintenance of
epithelial tissues (Arnold et al., 2011) that
has also been noted to be a frequently
amplified oncogene across a variety of
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Previewssquamous cell carcinomas (SCCs) (Bass
et al., 2009). In this issue of Cell Stem
Cell, Jianwen Que and colleagues show
that forced expression of SOX2 augments
proliferation and blocks the maturation of
foregut stem/progenitor cells. Addition-
ally, through analyses of squamous
tumors occurring in the squamous forest-
omach of SOX2-expressing mice, they
also identify a novel oncogenic synergism
of SOX2 with inflammation and STAT3
activity.
SOX2, a SRY-related HMG box tran-
scription factor, would appear to need
no introduction to this readership, given
its critical role in pluripotent stem cells
and its membership in the original quartet
of factors able to induce pluripotency
(Sarkar and Hochedlinger, 2013). Beyond
its role in pluripotency, however, Sox2
is also active later in development and
in the adult in many stem/progenitor
populations. Elegant work from Jianwen
Que during his time in the laboratory of
Brigid Hogan demonstrated that Sox2
is essential for the development and
maintenance of squamous precursors of
the foregut, the precursor to the esoph-
agus, stomach, trachea, and lungs (Que
et al., 2007, 2009). Additionally, in the
mature squamous esophagus, SOX2
(together with squamous transcription
factors p63, Keratin 5 [Krt5], and Nerve
Growth Factor Receptor [p75]) marks
the basal cell layers (Arnold et al.,
2011). By contrast, the suprabasal cells,
which are in the process of maturation
to differentiated squamous keratino-
cytes, show downregulation of both
SOX2 and p63. Although p63 had been
recognized for its role in squamous
neoplasia, at the time that SOX2’s role
in squamous physiology emerged, there
was no known link between SOX2 and
cancer. However, both SOX2 and TP63
lie on chromosome 3q, a region well
recognized to be subject to widespread
amplification in squamous cancers of
many lineages. With more refined
genomic technologies, it was shown
that SOX2 was indeed the focus of
high-level focal amplifications in lung
and esophageal SCCs and functioned
as an oncogene in these cancers
(Bass et al., 2009). SOX2 amplifications
are greatly enriched in SCCs compared
to adenocarcinomas, suggesting a
connection between SOX2’s role in
SCCs and its normal actions specificallyin squamous tissues. However, SOX2
overexpression alone appeared insuffi-
cient to induce transformation, and the
exact role of SOX2 in cancer remained
elusive.
In this issue of Cell Stem Cell, Li et al.
utilized an inducible SOX2 allele driven
by KRT5-CRE-ER to enable forced
expression in the basal foregut progenitor
cells. As might be predicted, there was
an expansion of the SOX2/p63-positive
basal-type progenitor cell population
exhibiting both enhanced rates of prolifer-
ation and reduced differentiation of pro-
genitors into mature squamous cells (Li
et al., 2013). Recently, a study by Doupe´
and colleagues suggested that there
may be only a single population of rapidly
cycling progenitors in the esophageal
squamous epithelium, with the size of
the progenitor pool determined by
stochastic divisions into differentiated or
cycling daughter cells (Doupe´ et al.,
2012). SOX2 overexpression appears to
shift the balance of daughter cell fate
toward an excess of proliferating progen-
itors and away from mature squamous
keratinocytes, thus expanding the poten-
tial pool of cancer-initiating cells.
Most strikingly, the authors found inva-
sive squamous tumors in these mice, with
the tumors present only within the KRT5+
squamous forestomach (an anatomical
site present in rodents, but not humans),
but not in the squamous esophagus
despite the presence of basal hyperplasia
in the esophagus. Comparative analyses
of the hyperplastic forestomach and the
esophagus revealed greater histopatho-
logic inflammation and inflammatory
gene expression signatures in the forest-
omach. In particular, immunostaining
showed increased F4/80+ macrophages
and Ly6C+ myeloid cells in the forestom-
ach, along with increased levels of IL-1b
and IL-6 mRNA. Ly6C+ has been
commonly used as a marker for myeloid-
derived suppressor cells (MDSCs), which
are immature myeloid cells known to
express IL-1b and IL-6 and are strongly
linked to carcinogenesis of the upper
GI tract (Tu et al., 2008). IL-1b produced
by myeloid cells typically induces IL-6,
which is a cytokine known to activate
(through GP130 and JAK) the transcrip-
tion factor STAT3. Activated (phospho-)
STAT3 has long been recognized as
an oncogene, and through analyses of
transcriptional networks in tumors,Cell Stem CellSTAT3 has frequently been identified as
a master regulator of transformation
(Carro et al., 2010). To test whether the
inflammation present within the stomach
was indeed responsible for the induction
of these cancers, the authors demon-
strated their ability to inhibit tumor for-
mation with either the anti-inflammatory
agent dexamethasone or pharmacologic
inhibition of STAT3. Further, to demon-
strate that there was no other resistance
to transformation in esophageal basal
hyperplasia, they showed that the
SOX2-expressing cells in the murine
esophagus, as well as SOX2-expressing
immortalized human esophageal kerati-
nocytes, could be transformed when
manipulated in vitro with ectopic acti-
vated STAT3 expression.
Human esophageal SCCs are more
commonly seen in the upper esophagus
and are most strongly associated with
alcohol and tobacco exposure as risk
factors, in contrast to the likely gastric-
acid-related forestomach tumors that
arise in the murine models. Nevertheless,
a common feature in both systems is
the carcinogen-dependent induction of
chronic inflammation, leading to upregu-
lation of STAT3. Indeed, the investigators
demonstrate a frequent co-occurrence of
expression of SOX2 and phosphorylated
STAT3 across a collection of human
esophageal SCCs, and modest STAT3
dependency with RNA interference in
a human esophageal squamous cancer
cell line.
Overall, Li et al. clearly demonstrate the
ability of dysregulated SOX2 expression
in the foregut to lead to expansion and
blocked maturation of squamous pre-
cursor cells. However, such an expansion
is in itself not a sufficient cause of malig-
nant transformation but requires another
cooperative event for cancer initiation.
As this article demonstrates for the first
time, inflammation and STAT3 activation
can collaborate with SOX2 in the induc-
tion of squamous cancers. Similar to
previous models, IL-1-expressing mye-
loid cells are once again implicated in
the initiation as well as the promotion of
tumorigenesis. Future investigations will
be able to further define the immune cells
that serve as critical collaborators in the
development of SCCs, as well other
inflammatory factors that can similarly
collaborate with SOX2 to drive human
cancer.12, March 7, 2013 ª2013 Elsevier Inc. 267
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